Teikoku Pharma USA
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Teikoku Pharma USA
Korean Bioventure Financing Continues Downward Spiral In Q3
VC Investment in South Korea’s biopharma sector drops again as investors continue to shy away amid higher interest rates and reduced out-licensing deals.
Going Early For Maximum Long Term Value From Medtech Deals
Strategics pursuing high growth M&A plays are often ready to pay a premium price for a target. But with medtech valuations at historic highs, they cannot afford to do that every time. One solution is to take a strategic stake and build early, according to an AdvaMed panel hosted by EY’s John Babitt.
JPM 2022 Mid-Week IVD Roundup: Guardant, Illumina, Ortho Clinical, Thermo Fisher
The annual J.P. Morgan Healthcare Conference includes presentations from major medtech companies describing their experience in 2021 and expectations for 2022. Here are some highlights from the in vitro diagnostics companies that presented on the first two days of the meeting.
Minute Insight: Quidel And Labcorp Finish Big Year For IVD Deals With Major Acquisitions
Quidel will pay $6bn for Ortho Clinical Diagnostics. Labcorp will acquire Personal Genome Diagnostics for $575m.
- Medical Devices
- Drug Delivery
- Generic Drugs
- OTC, Consumer
- Other Names / Subsidiaries
- Travanti Pharma, Inc.
- Birch Point Medical, Inc.
- Teikoku Seiyaku
- Teikoku Seiyaku Co., Ltd.
All set! This article has been sent to firstname.lastname@example.org.
All fields are required. For multiple recipients, separate email addresses with a semicolon.